NCT05962801 is a NA clinical trial of Lumoral device, Lumorinse in Periodontitis, sponsored by Aristotle University Of Thessaloniki.

Who is sponsoring NCT05962801?

NCT05962801 is sponsored by Aristotle University Of Thessaloniki.

What drugs are being tested in NCT05962801?

Interventions in NCT05962801: Lumoral device, Lumorinse.

What condition does NCT05962801 study?

NCT05962801 studies Periodontitis, Dual- Light Photodynamic Therapy, Smoking, Cigarette, Non-surgical Periodontal Therapy.

Is NCT05962801 still recruiting?

NCT05962801 is currently status unknown. Last updated 4 October 2023.

Last reviewed 2023-10-04 · How we verify

NCT05962801

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Use of Dual-light Photodynamic Therapy as an Adjunct to Periodontal Treatment in Smokers

Status unknown NA Last updated 4 October 2023

What this trial tests

NA trial testing Lumoral device, Lumorinse in Periodontitis in 60 participants. Status unknown.

Timeline

23 January 2023

Primary endpoint
1 June 2024

1 September 2024

Quick facts

Lead sponsor	Aristotle University Of Thessaloniki
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	23 January 2023
Primary completion	1 June 2024
Estimated completion	1 September 2024
Sites	1 location across Greece

Drugs / interventions tested

Lumoral device, Lumorinse

Conditions studied

Periodontitis — all drugs for Periodontitis →
Dual- Light Photodynamic Therapy — all drugs for Dual- Light Photodynamic Therapy →
Smoking, Cigarette — all drugs for Smoking, Cigarette →
Non-surgical Periodontal Therapy — all drugs for Non-surgical Periodontal Therapy →

Sponsor

Aristotle University Of Thessaloniki

Who can join

35 and older, any sex, with Periodontitis or Dual- Light Photodynamic Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this controlled clinical trial is to investigate the impact of regular home use of Lumoral device as an adjunct treatment compared to non-surgical periodontitis treatment (NSPT) alone on biofilm removal and host response in Stage III and Grade C smoking periodontitis patients at 6 months.The main question aims to answer is: • Does regular use of dual-light photodynamic therapy benefit NSPT in Stage III and Grade C smoking periodontitis patients? 30 participants will be asked to use Lumoral device every night before performing oral hygiene for 10 minutes, while the other 30 patients will be asked to perform only oral hygiene. Both of these groups will receive NSPT and will be followed for 6 months from baseline.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Regular home use of dual-light photodynamic therapy as an adjunct to non-surgical periodontal treatment in smokers: a single-center randomized controlled clinical trial.
Vakaki C, Fragkioudakis I, Pätilä T, Sakellari D. · · 2025 · PMID 41196397 · DOI 10.1007/s00784-025-06600-1

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07535177 — Gas6 and Soluble MerTK in Periodontal Diseases · recruiting
NCT07491848 — Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+D · recruiting
NCT07421960 — Investigation of the Relationship Between Periodontitis and Sleep Quality · recruiting
NCT07532694 — Diode Laser-Assisted Periodontal Therapy in Kidney Transplant Recipients · NA · recruiting

Other Aristotle University Of Thessaloniki trials

Trials by the same sponsor.

NCT07382479 — NeoAdjuvant ChemoTherapy With KELIM Guided Interval vs. Delayed Interval Debulking Surgery · NA · not yet recruiting
NCT07379905 — MODUCARE Versus Wait-and-See Approach for Histologically Proven Low-grade Cervical Intraepithelial Neoplasia (CIN1) · NA · not yet recruiting
NCT07335016 — The Role of Follicular Flushing at Oocyte Retrieval · NA · not yet recruiting
NCT07297121 — Validation of the Montreal Cognitive Assessment (MoCA) Version 8.x and MoCA-MIS in Greece. · not yet recruiting
NCT07210164 — Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05962801 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aristotle University Of Thessaloniki
Last refreshed: 4 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05962801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing